RGH-706

N/A

Report date: 2024/11/29 20:00:39

Base Information

Drug NameRGH-706
Drug Alias NameRGH-706
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanin-concentrating hormone receptor 1 inhibitors
TargetsMelanin-concentrating hormone receptor 1
Therapy Area/IndicationsPrader-Willi Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesItaly +[5] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGedeon Richter Plc
China Registration ClassN/A

Develop Information

Active CompaniesGedeon Richter Plc
Inactive CompaniesN/A
Active IndicationsPrader-Willi Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A